60 Degrees Pharmaceuticals, Inc. SXTP 深 滬
已收盤 04-02 16:00:00 美东时间
1.86
-0.010
-0.53%
華盛通- 最 高1.94
- 今 開1.79
- 成交量 6.41万股
- 最 低 1.75
- 昨 收 1.87
- 總市值 490.44万
- 52周最高 17.68
- 市盈率 靜 --
- 換手率 2.43%
- 52周最低 1.29
- 委 比 96.81%
- 總股本 263.68万
- 歷史最高 2076.00
- 量 比 0.16
- 振 幅 10.16%
- 歷史最低 1.36
- 每 手 1
- 風險率 2.95%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多60 Degrees Pharmaceuticals shares are trading higher. The company reported its Q4 financial results.
60 Degrees Pharmaceuticals shares are trading higher. The company reported its ...
03-31 23:46
60 Degrees Q4 EPS $(1.47) Misses $(1.12) Estimate, Sales $303.385K Miss $400.000K Estimate
60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(1.47) per share which missed the analyst consensus estimate of $(1.12) by 31.25 percent. This is a 97.41 percent increase over losses of $(56.80) per share from the
03-31 19:50
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification With FDA For Australian Chestnut Extract; Inks Deal To License Florida State University's Ownership Rights To New Capsule Formulation Methods For Australian Chestnut Extract
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees Pharma" or the "Company"), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced it submitted a
03-18 20:10
What's Going On With 60 Degrees Pharmaceuticals On Friday?
60 Degrees Pharma shares fall premarket after a huge rally as its babesiosis trial reports a 100% cure rate with tafenoquine treatment.
03-13 21:11
60 Degrees Pharmaceuticals Says All Three Patients Cured Of Babesiosis After Tafenoquine Treatment In Expanded Use Clinical Trial
All three patients enrolled in study have been cured, confirming high cure rate of tafenoquine in immunosuppressed patients, as reported by Yale in a 2024 publicationCompany calls for existing babesiosis treatment
03-11 19:26
60 Degrees Pharma shares are trading lower. The company announced a partnership with GoodRx to offer eligible consumers savings of up to 30% on ARAKODA.
60 Degrees Pharma shares are trading lower. The company announced a partnership...
02-03 03:00
美股大行评级 | 瑞穗上调希捷科技、西部数据、CoreWeave目标价；Trade Desk、W.R. Berkley遭多家大行下调目标价
今日重点评级关注：瑞穗：维持Syndax制药"跑赢大市"评级，目标价从410美元升至600美元；HC Wainwright & Co.：维持60 Degrees Pharmaceuticals, Inc."买入"评级，目标价从6美元升至24美元
01-28 10:59
60 Degrees Pharmaceuticals shares are trading higher after the company announced a partnership with Runway Health to expand pre-departure access to ARAKODA.
60 Degrees Pharmaceuticals shares are trading higher after the company announce...
01-22 21:07
60 Degrees Pharmaceuticals Identifies Babesia Parasite In 24% Of Participants In Group Of 50 Patients With Chronic Fatigue
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees Pharma" or the "Company"), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced that infection
2025-12-29 21:11
60 Degrees Pharma To Expand ARAKODA Sales And Marketing, Adding Reps, GoodRx Partnership And Enhanced Digital Campaign
6-month commercial pilot demonstrated increasing demand among prescribersExpansion plan includes doubling the number of sales reps, a new GoodRx partnership, and enhanced digital marketing campaignAdditional clinical
2025-12-11 21:19
